University of Pittsburgh School of Medicine, PA, USA.
University of Pittsburgh Medical Center, PA, USA.
Hand (N Y). 2024 Mar;19(2):212-216. doi: 10.1177/15589447221127336. Epub 2022 Oct 2.
We hypothesized that postoperative Boston Carpal Tunnel Questionnaire (BCTQ) scores and ultrasound (US) measurements of the median nerve cross-sectional area (CSA) at the distal wrist crease are significantly decreased at 2-week, 6-week, and ≥ 6 months follow-up appointments, compared with baseline values.
This study was a retrospective chart review of patients who presented to a single hand clinic with evidence of carpal tunnel syndrome over a 6-year period (2014-2020). Patients received baseline US measurements of the median nerve CSA as well as completion of the BCTQ, and for the patients who underwent carpal tunnel release (CTR), postoperative US measurements and questionnaire scores were obtained at 2 weeks, 6 weeks, or ≥ 6 months postoperatively.
This study included 224 separate wrists. Median Nerve CSA measurements were 13.2 ± 4.5 mm at baseline, 11.9 ± 3.6 mm at 2 weeks postoperatively, 11.6 ± 4.5 mm at 6 weeks postoperatively, and 11.7 ± 4.3 mm at 6 months or more ( = .002). The BCTQ Symptom Severity Scale scores were 3.14 ± 0.76 at baseline, 1.76 ± 0.63 at 2 weeks, 1.68 ± 0.70 at 6 weeks, and 1.41 ± 0.64 at 6 months or longer ( < .001). The BCTQ Functional Status Scale scores were 2.56 ± 0.89 at baseline, 2.03 ± .1.0 at 2 weeks, 1.65 ± 0.77 at 6 weeks, and 1.36 ± 0.61 at 6 months or longer ( < .001).
These findings demonstrated a sustained decrease in median nerve CSA and patient-reported outcomes following CTR at 2 weeks, 6 weeks, and between 6 and 12 months.
我们假设与基线值相比,术后波士顿腕管问卷(BCTQ)评分和在远侧腕横纹处正中神经横截面积(CSA)的超声(US)测量值在 2 周、6 周和≥6 个月随访时明显降低。
本研究是对在 6 年期间(2014-2020 年)因腕管综合征就诊于单一手部诊所的患者进行的回顾性图表审查。患者接受基线正中神经 CSA 的 US 测量以及 BCTQ 的完成,对于接受腕管松解术(CTR)的患者,在术后 2 周、6 周或≥6 个月获得术后 US 测量和问卷评分。
这项研究包括 224 个单独的手腕。正中神经 CSA 测量值在基线时为 13.2 ± 4.5mm,术后 2 周时为 11.9 ± 3.6mm,术后 6 周时为 11.6 ± 4.5mm,术后 6 个月或更长时间时为 11.7 ± 4.3mm( =.002)。BCTQ 症状严重程度量表评分为 3.14 ± 0.76 分,术后 2 周为 1.76 ± 0.63 分,术后 6 周为 1.68 ± 0.70 分,术后 6 个月或更长时间为 1.41 ± 0.64 分(<.001)。BCTQ 功能状态量表评分为 2.56 ± 0.89 分,术后 2 周为 2.03 ±.1.0 分,术后 6 周为 1.65 ± 0.77 分,术后 6 个月或更长时间为 1.36 ± 0.61 分(<.001)。
这些发现表明在 CTR 后 2 周、6 周和 6 至 12 个月之间,正中神经 CSA 和患者报告的结果持续减少。